Plain-English translation of NCT06637436 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a combination of motivational counseling and financial rewards can help men who use methamphetamine start taking PrEP (a daily medication that prevents HIV) or receive HIV treatment. The study compares two approaches: one group receives financial incentives alone, while another group receives counseling plus incentives. All support is delivered online over 12 months.
Men who use methamphetamine face unique barriers to starting and staying on HIV prevention — including stigma, addiction challenges, and depression. This trial wants to find the best way to support them in taking these life-saving medications.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either financial incentives alone ($50 for starting HIV care, $50 for filling a prescription) or the same incentives plus two counseling sessions focused on motivation. All support happens through telehealth (video or phone). You'll complete check-ins each month for 12 months, answering questions about your health, substance use, and sexual health. You'll also need to provide a photo of your filled prescription as verification.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States
Florida International University
Enrollment target
~400 participants
Started
January 2025
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Adam Carrico Professor, PhD
Florida International University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.